Eloxx Pharmaceuticals, Inc. (ELOX) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

Eloxx Pharmaceuticals, Inc. (ELOX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $95.3M, listed on NASDAQ, employing roughly 10 people, carrying a beta of -24.60 to the broader market. Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical firm that specializes in developing therapeutic solutions through ribosome modulation. Led by Sumit Aggarwal, public since 2026-06-09.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for ELOX as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →